KFA
TEVA icon

Kelleher Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Kelleher Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67,600
Closed -$72K – 130
2016
Q4 		$72K Sell
67,600
-1,800
-3% -$71.9K 0.04% 134
2016
Q3 		$3.19M Buy
69,400
+7,300
+12% +$381K 1.81% 16
2016
Q2 		$3.12M Hold
62,100
– – 1.89% 16
2016
Q1 		$3.32M Sell
62,100
-300
-0.5% -$17.6K 1.83% 14
2015
Q4 		$4.09M Sell
62,400
-1,900
-3% -$117K 2.78% 8
2015
Q3 		$3.63M Sell
64,300
-1,200
-2% -$77.8K 2.41% 9
2015
Q2 		$3.87M Sell
65,500
-100
-0.2% -$6.17K 2.21% 12
2015
Q1 		$4.09M Sell
65,600
-400
-0.6% -$23.3K 2.26% 8
2014
Q4 		$3.79M Buy
66,000
+500
+0.8% +$27.9K 2.04% 14
2014
Q3 		$3.69M Sell
65,500
-100
-0.2% -$5.3K 2% 14
2014
Q2 		$3.44M Sell
65,600
-150
-0.2% -$7.67K 1.79% 16
2014
Q1 		$3.47M Buy
65,750
+2,100
+3% +$97.1K 1.89% 14
2013
Q4 		$2.55M Buy
63,650
+2,100
+3% +$82.7K 1.32% 24
2013
Q3 		$2.33M Buy
61,550
+2,350
+4% +$91.7K 1.33% 26
2013
Q2 		$2.32M Buy
+59,200
New +$2.31M 1.42% 25

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kelleher Financial Advisors's TEVA Position: Q1 2017 in Review

Kelleher Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 67,600 shares — an estimated $72K sold.

Kelleher Financial Advisors first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $4.09M in Q4 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Kelleher Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Kelleher Financial Advisors sold 67,600 Teva Pharmaceuticals shares in Q1 2017, an estimated $72K.
  • Kelleher Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Kelleher Financial Advisors's Teva Pharmaceuticals position peaked at $4.09M in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Kelleher Financial Advisors's 13F filing for Q1 2017, filed 12 May 2017.